Showing results (171-180 of 214) with videos related to
Sort By:
Pageof 22
Journal of Alzheimer'S Disease : JAD|November 21, 2017
Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's DiseaseNoam Y Kirson, J Scott Andrews, Urvi Desai, et al.Journal of Medical Economics|March 13, 2015
The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular riskM S Penn, M A Yenikomshian, A K G Cummings, et al.Journal of Medical Economics|March 20, 2015
Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcersJ Bradford Rice, Urvi Desai, Ljubica Ristovska, et al.The American Journal of Managed Care|August 20, 2011
Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insuranceJasmina I Ivanova, Howard G Birnbaum, Lei Chen, et al.Hippocampus|November 27, 2014
Retrieval of morphine-associated context induces cFos in dentate gyrus neuronsPhillip D Rivera, Ramya K Raghavan, Sanghee Yun, et al.Journal of Occupational and Environmental Medicine|February 24, 2001
Depression and work productivity: the comparative costs of treatment versus nontreatmentG E Simon, C Barber, H G Birnbaum, et al.Cell Reports|April 6, 2024
Female-specific dysfunction of sensory neocortical circuits in a mouse model of autism mediated by mGluR5 and estrogen receptor αGemma Molinaro, Jacob E Bowles, Katilynne Croom, et al.Journal of Medical Economics|August 6, 2010
Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalinNoam Y Kirson, Jasmina I Ivanova, Howard G Birnbaum, et al.Journal of Medical Economics|August 6, 2010
Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%Noam Y Kirson, Jasmina I Ivanova, Howard G Birnbaum, et al.Diabetes Research and Clinical Practice|November 10, 2009
Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysisLauren J Lee, Andrew P Yu, Scott J Johnson, et al.Pageof 22